AstraZeneca vet Jennifer Butler takes charge of Innate Pharma’s US biz; C4 raids NIBR

? France?s Innate Pharma has wooed AstraZeneca vet Jennifer Butler to lead the US operations it has set up after acquiring Lumoxiti from the British drugmaker in a rich add-on collaboration deal. Butler?s official title will be EVP and general manager of Innate Pharma US. Most recently, she was chief business officer, chief commercial officer and head of US operations at Tessa Therapeutics.

? After celebrating the approval of a Parkinson?s therapy he helped acquired for Acorda Therapeutics,